Where Science Meets Real-World Applications
ATTD-ASIA is a groundbreaking expansion of ATTD – the leading international meeting point where clinicians, diabetes care providers, researchers, industries, investors, reimbursement authorities, and people with diabetes assemble with the aim of sharing knowledge and developing collaborations.
We’re working to provide a Scientific Program filled with the latest therapies for diabetes management!
You are invited to explore the initial Scientific Program structure
* Subject to changes. Correct as of 1 June 2026
Initial Titles & Speakers
Opening Lecture: Toward the Development of Personalized Diabetes Care
Kohjiro Ueki, JapanEducation and Early Career Development for Diabetes Care Teams
Anastasia Albanese-O’Neill, USA
Using CGM to Understand Preeclampsia
Naoko Arata, Japan
Prevalence of Other Types of Diabetes in Asia
Juliana Chan, Hong Kong PRC
AI and Hypoglycemia Prediction
Pratik Choudhary, UK
CGM and AID in Chronic Kidney Disease
Elaine Chow, Hong Kong PRC
Strategies To Improve Clinical Adoption for Emerging Therapies for Type 1 Diabetes
Thomas Danne, Portugal
Move to Improve: Co-Designing a Hospital-Based Physical Activity Program for Children With Chronic Health Conditions
Elizabeth Davis, Australia
Most Youth with Diabetes Using Advanced Hybrid Closed-Loop Therapy Don’t Attain Glycaemic Targets: What More Can We Do?
Responsible AI Use in Diabetes Care
Amit Dey, India
Using GLP-1 Analogues to Prevent Gestational Diabetes
Judie Dodd, Australia
Exercise and Type 1 Diabetes
Klemen Dovc, Slovenia
Diabetes in Asia: Implications for Subtyping; and CGM Accuracyf
Daphne Gardner, Singapore
Consensus on Incretin Use
in T1D
Satish Garg, USA
Regional Perspectives Regarding Diabetes Technology
Amit Gupta, India
Youth-Onset T2D in Asia:
Bridging Guidelines and Real-World Practice
Muhammad Yazid Jalaludin, Malaysia
Evaluation Of CGM-Based Insulin Dose Guidance System In People With T1D And T2D: Single-Arm Feasibility Study
Andrej Janež, Slovenia
The Role of EMRs in India
Jothydev Kesavadev, India
CGM and Smart Pens in People
Living With T2D Using Insulin
Jae Hyeon Kim, Korea
National Big Data-Based Insights Into Pediatric Diabetes Epidemiology and Complications
Jae Hyun Kim, Korea
Using Longitudinal Data Collection to Improve Outcomes for People With Different Stages of Type 1 Diabetes in Japan
Noriko Kodani, Japan
Using Longitudinal Data Collection to Improve Outcomes for People With Different Stages of Type 1 Diabetes in Japan
Noriko Kodani, Japan
Frailty Changes The Diabetes Playbook: Lifestyle Medicine That Protects Function
Eng Sing Lee, Singapore
CGM Metrics for Predicting GDM
in Asia
Queenie Ling Jun Li, Singapore
Precision Diagnostics and
Therapeutics in Young-Onset Diabetes in Asia
Ronald CW Ma, Hong Kong PRC
The Use of Diabetes Tech in the Elderly
Julia Mader, Austria
CGM Adoption in India and Challenges
Anuj Maheshwari, India
Prerequisites for Accelerating Clinical Adoption of Cell Therapy in T1D
Brynn Marks, USA
Monogenic Diabetes and Its Prevalence in Asia
Viswanathan Mohan, India
Continuous Glucose Monitoring in Gestational Diabetes
Sun-Joon Moon, Republic of Korea
AI in Diabetes Care: Tool, Teammate, or Decision-Maker?
Revital Nimri, Israel
New Pharmacological Treatment in Children With Type 2 Diabetes
Rimei Nishimura, Japan
Integrating CGM and Automation
of Insulin Delivery Into Hospital Care
David O’Neal, Australia
Novel Avenues for Potential Future Therapies Aimed at Improving Metabolic Control in Diabetes (Gene Therapies, Endoluminal Resurfacing)
David O’Neal, Australia
Lifestyle Medicine: The Six Pillars—Do We Practice What We Preach?
Emina Obarcanin, Singapore
From Prediction to Prevention: AI-Driven Early Detection of Type 1 Diabetes
Tal Oron, Israel
Exercise and Type 1 Diabetes
Takafumi Osaka, Japan
Cell-Based Therapies in Type 1 Diabetes
Lorenzo Piemonti, Italy
Transforming Diabetes Care With Lifestyle Medicine
Siva Poobalasingam, Malaysia
Medical Insights From CGM Beyond Glucose Control
Sarah Price, Australia
CGM-Detected Nocturnal Hypoglycemia and Sleep
Suresh Rama Chandran, Singapore
CGM Metrics in People Without Diabetes in Asia: Differentiating Prediabetes From Normoglycemia
Suresh Rama Chandran, Singapore
CGM in T2D: From Early Intervention to Management
Banshi Saboo, India
Evidence of Using AID in T2D and How AID Could Reduce Therapeutic Inertia
Viral Shah, USA
Barriers to CGM Use as a Behavioral Tool
Amit Shapira, USA
Sex Differences in Continuous Glucose Monitoring Profiles: Insights From a Non-Diabetic Population
Smadar Shilo, Israel
What Can a CGM Signal Tell Us About
Insulin Resistance in Non-Diabetic
Adults?
Smadar Shilo, Israel
Using GLP-1 RA With Exercise
in T1D
Stephen Twigg, Australia
How Can We Screen Children for T2D?
Tatsuhiko Urakami, Japan
From Incretin-Based Therapies to iPSC-Based Regenerative Medicine: New Frontiers in Diabetes Care
Daisuke Yabe, Japan
Clinical Implications of TIR, CV, and GRI
Jee Hee Yoo, Republic of Korea
Clinical Utility and Interpretation of CGM in Prediabetes
Jee Hee Yoo, Republic of Korea